Plans to Remove Potentially Carcinogenic Contaminants from Januvia, Janumet Outlined By Merck
Merck indicates it will remove nitrosamine contaminants from Januvia and Janumet by the end of 2023.
Tag Archives: Valsartan
-
-
Valsartan NDMA Lawsuits Cleared To Move Forward, After Motion for Reconsideration Rejected
A federal judge has cleared Valsartan NDMA lawsuits to proceed after rejecting a call by defendants to reconsider the admissibility of plaintiffs' expert witnesses following the recent dismissal of Zantac…
-
Discovery of Cancer-Causing Chemicals in Zantac, Sunscreen and Other Products Highlights FDA Failures: Bloomberg
A Bloomberg report highlights how the independent laboratory, Valisure, has consistently discovered dangerous, potentially cancer-causing chemicals in products like Zantac and sunscreen before the FDA.
-
Nitrosamines Problems Are More Widespread in Drugs Than FDA Anticipated: Report
The FDA has been caught off-guard by the number of drugs being recalled for nitrosamine contamination and is likely to update a 2020 guidance to better address the problem according…
-
Potentially Cancer-Causing Contaminant Found In Januvia: FDA
Some batches of Januvia, a diabetes drug, contain high levels of nitrosamines which could increase cancer risks, the FDA warns.
-
Valsartan Settlement Masters Appointed To Advance Negotiations in MDL
Two former district judges have been appointed as valsartan settlement special masters to help bring about a resolution to the litigation.
-
Accuretic Recall Announced In Canada Over Nitrosamine Contamination In Another Pfizer Hypertension Drug
Canadian health regulators have announced an Accuretic recall, indicating the Pfizer hypertension drug contains levels of cancer-causing chemicals above the acceptable amounts.
-
Extended Use of Valsartan and Other Angiotensin-Receptor Blockers May Increase Cancer Risk: Study
Valsartan and similar hypertension drugs may carry an increased risk of cancer with long-term use, according to the findings of a new study.
-
Generic Metformin Recall Issued Over NDMA Contamination
Dozens of batches of generic metformin are being recalled due to the presence of NDMA; a cancer-causing chemical byproduct which has led to numerous drug recalls in recent years.
-
Sanctions Granted Against Valsartan Manufacturer for Discovery Abuses
A Special Master involved in valsartan litigation has determined Zhejiang Huahei Pharmacticals, the manufacturer of the active ingredient, should pay sanctions for failing to provide appropriate answers to some questions…
